Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Cytokeratin 15

Path Created with Sketch.
Go to Cytokeratin 15 Normal Tissue GalleryGo back to Product Page
Breast - Invasive breast cancer of no special type (NST) showing moderate to strong CK15 immunostaining in tumor cells.
Breast – Invasive breast cancer of no special type (NST) showing moderate to strong CK15 immunostaining in tumor cells.
Breast - Strong CK15 immunostaining of all cells of an invasive lobular breast cancer.
Breast – Strong CK15 immunostaining of all cells of an invasive lobular breast cancer.
Breast - Weak to moderate CK15 immunostaining in the majority of cells of an invasive breast cancer of no special type (NST).
Breast – Weak to moderate CK15 immunostaining in the majority of cells of an invasive breast cancer of no special type (NST).
Esophagus - Squamous cell carcinoma showing strong CK15 immunostaining.
Esophagus – Squamous cell carcinoma showing strong CK15 immunostaining.
Kidney - Cytokeratin 15 negative clear cell renal cell carcinoma.
Kidney – Cytokeratin 15 negative clear cell renal cell carcinoma.
Liver - Cholangiocellular carcinoma showing weak to moderate CK15 immunostaining in most tumor cells.
Liver – Cholangiocellular carcinoma showing weak to moderate CK15 immunostaining in most tumor cells.
Lung - Moderate to strong CK15 immunostaining in a pulmonary adenocarcinoma.
Lung – Moderate to strong CK15 immunostaining in a pulmonary adenocarcinoma.
Lung - Squamous cell carcinoma showing strong CK15 immunostaining.
Lung – Squamous cell carcinoma showing strong CK15 immunostaining.
Oral cavity - Squamous cell carcinoma with strong CK15 staining.
Oral cavity – Squamous cell carcinoma with strong CK15 staining.
Ovary - Brenner tumor showing moderate Cytokertin 15 staining in tumor cells.
Ovary – Brenner tumor showing moderate Cytokertin 15 staining in tumor cells.
Pancreas - Cytokeratin 15 negative neuroendocrine tumor.
Pancreas – Cytokeratin 15 negative neuroendocrine tumor.
Prostate - Cytokeratin 15 negative prostatic adenocarcinoma (Gleason 3+3=6). Few normal glands show staining of basal cells.
Prostate – Cytokeratin 15 negative prostatic adenocarcinoma (Gleason 3+3=6). Few normal glands show staining of basal cells.
Skin - Basal cell carcinoma with strong CK15 immunostaining.
Skin – Basal cell carcinoma with strong CK15 immunostaining.
Skin - Cytokeratin 15 negative Merkel cell carcinoma.
Skin – Cytokeratin 15 negative Merkel cell carcinoma.
Skin - Squamous cell carcinoma showing strong CK15 immunostaining.
Skin – Squamous cell carcinoma showing strong CK15 immunostaining.
Stomach- Cytokeratin negative gastric adenocarcinoma (intestinal type).
Stomach- Cytokeratin negative gastric adenocarcinoma (intestinal type).
Testis - Cytokeratin 15 negative seminoma.
Testis – Cytokeratin 15 negative seminoma.
Urinary bladder - Strong Cytokeratin 15 positivity in a muscle-invasive urothelial carcinoma.
Urinary bladder – Strong Cytokeratin 15 positivity in a muscle-invasive urothelial carcinoma.
Vagina - Squamous cell carcinoma showing strong CK15 immunostaining.
Vagina – Squamous cell carcinoma showing strong CK15 immunostaining.
Vulva - Squamous cell carcinoma with strong CK15 positivity.
Vulva – Squamous cell carcinoma with strong CK15 positivity.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors